• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

联合抑制 JAK1、2/Stat3-PD-L1 信号通路抑制缺氧状态下去势抵抗性前列腺癌对 NK 细胞的免疫逃逸。

Combined inhibition of JAK1,2/Stat3‑PD‑L1 signaling pathway suppresses the immune escape of castration‑resistant prostate cancer to NK cells in hypoxia.

机构信息

Department of Urology, The Second Affiliated Hospital of Soochow University, Suzhou, Jiangsu 215004, P.R. China.

Department of Ultrasound, The Second Affiliated Hospital of Soochow University, Suzhou, Jiangsu 215004, P.R. China.

出版信息

Mol Med Rep. 2018 Jun;17(6):8111-8120. doi: 10.3892/mmr.2018.8905. Epub 2018 Apr 20.

DOI:10.3892/mmr.2018.8905
PMID:29693186
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5983983/
Abstract

Castration‑resistant prostate cancer (CRPC) is difficult to treat in current clinical practice. Hypoxia is an important feature of the CRPC microenvironment and is closely associated with the progress of CRPC invasion. However, no research has been performed on the immune escape of CRPC from NK cells. The present study focused on this subject. Firstly, when the CRPC cell lines C4‑2 and CWR22Rv1 were induced by hypoxia, the expression of the UL16 binding protein (ULBP) ligand family of natural killer (NK) group 2D (NKG2D; ULBP‑1, ULBP‑2 and ULBP‑3) and MHC class I chain‑related proteins A and B (MICA/MICB) decreased. NKG2D is the main activating receptor of NK cells. Tumor cells were then co‑cultured with NK cells to conduct NK cell‑mediated cytotoxicity experiments, which revealed the decreased immune cytolytic activity of NK cells on hypoxia‑induced CRPC cells. In exploring the mechanism behind this observation, an increase in programmed death‑ligand 1 (PD‑L1) expression in CRPC cells induced by hypoxia was observed, while the addition of PD‑L1 antibody effectively reversed the expression of NKG2D ligand and enhanced the cytotoxic effect of NK cells on CRPC cells. In the process of exploring the upstream regulatory factors of PD‑L1, inhibition of the Janus kinase (JAK)1,2/signal transducer and activator of transcription 3 (Stat3) signaling pathway decreased the expression of PD‑L1 in CRPC cells. Finally, it was observed that combined inhibition of JAK1,2/PD‑L1 or Stat3/PD‑L1 was more effective than inhibition of a single pathway in enhancing the immune cytolytic activity of NK cells. Taking these results together, it is thought that combined inhibition of the JAK1,2/PD‑L1 and Stat3/PD‑L1 signaling pathways may enhance the immune cytolytic activity of NK cells toward hypoxia‑induced CRPC cells, which is expected to provide novel ideas and targets for the immunotherapy of CRPC.

摘要

去势抵抗性前列腺癌(CRPC)在当前的临床实践中难以治疗。缺氧是 CRPC 微环境的一个重要特征,与 CRPC 侵袭的进展密切相关。然而,目前还没有研究针对 CRPC 从 NK 细胞中免疫逃逸的问题。本研究对此进行了探讨。首先,当 CRPC 细胞系 C4-2 和 CWR22Rv1 被诱导缺氧时,NK 细胞的自然杀伤(NK)组 2D(NKG2D)的 UL16 结合蛋白(ULBP)配体家族和 MHC 类 I 链相关蛋白 A 和 B(MICA/MICB)的表达降低。NKG2D 是 NK 细胞的主要激活受体。然后将肿瘤细胞与 NK 细胞共培养,进行 NK 细胞介导的细胞毒性实验,结果显示 NK 细胞对缺氧诱导的 CRPC 细胞的免疫细胞溶解活性降低。在探索这种观察结果的机制时,发现缺氧诱导的 CRPC 细胞中程序性死亡配体 1(PD-L1)的表达增加,而添加 PD-L1 抗体可有效逆转 NKG2D 配体的表达,增强 NK 细胞对 CRPC 细胞的细胞毒性作用。在探索 PD-L1 的上游调节因子的过程中,抑制 Janus 激酶(JAK)1、2/信号转导和转录激活因子 3(Stat3)信号通路降低了 CRPC 细胞中 PD-L1 的表达。最后观察到,联合抑制 JAK1、2/PD-L1 或 Stat3/PD-L1 比抑制单一通路更能增强 NK 细胞的免疫细胞溶解活性。综上所述,认为联合抑制 JAK1、2/PD-L1 和 Stat3/PD-L1 信号通路可能增强 NK 细胞对缺氧诱导的 CRPC 细胞的免疫细胞溶解活性,有望为 CRPC 的免疫治疗提供新的思路和靶点。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0952/5983983/23d7fe12525c/MMR-17-06-8111-g05.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0952/5983983/c9f4114464bb/MMR-17-06-8111-g01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0952/5983983/6570d7dd5363/MMR-17-06-8111-g02.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0952/5983983/d02670c48530/MMR-17-06-8111-g03.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0952/5983983/5aa1dcf493e4/MMR-17-06-8111-g04.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0952/5983983/23d7fe12525c/MMR-17-06-8111-g05.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0952/5983983/c9f4114464bb/MMR-17-06-8111-g01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0952/5983983/6570d7dd5363/MMR-17-06-8111-g02.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0952/5983983/d02670c48530/MMR-17-06-8111-g03.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0952/5983983/5aa1dcf493e4/MMR-17-06-8111-g04.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0952/5983983/23d7fe12525c/MMR-17-06-8111-g05.jpg

相似文献

1
Combined inhibition of JAK1,2/Stat3‑PD‑L1 signaling pathway suppresses the immune escape of castration‑resistant prostate cancer to NK cells in hypoxia.联合抑制 JAK1、2/Stat3-PD-L1 信号通路抑制缺氧状态下去势抵抗性前列腺癌对 NK 细胞的免疫逃逸。
Mol Med Rep. 2018 Jun;17(6):8111-8120. doi: 10.3892/mmr.2018.8905. Epub 2018 Apr 20.
2
Inhibition of IL-6-JAK/Stat3 signaling in castration-resistant prostate cancer cells enhances the NK cell-mediated cytotoxicity via alteration of PD-L1/NKG2D ligand levels.阻断白细胞介素 6-JAK/Stat3 信号通路可通过改变 PD-L1/NKG2D 配体水平增强去势抵抗性前列腺癌细胞的 NK 细胞介导的细胞毒性。
Mol Oncol. 2018 Mar;12(3):269-286. doi: 10.1002/1878-0261.12135. Epub 2018 Jan 24.
3
Adipocytes affect castration-resistant prostate cancer cells to develop the resistance to cytotoxic action of NK cells with alterations of PD-L1/NKG2D ligand levels in tumor cells.脂肪细胞通过改变肿瘤细胞中PD-L1/NKG2D配体水平,影响去势抵抗性前列腺癌细胞对NK细胞细胞毒性作用产生抗性。
Prostate. 2018 Apr;78(5):353-364. doi: 10.1002/pros.23479. Epub 2018 Jan 12.
4
ATM‑JAK‑PD‑L1 signaling pathway inhibition decreases EMT and metastasis of androgen‑independent prostate cancer.ATM-JAK-PD-L1 信号通路抑制降低雄激素非依赖性前列腺癌的 EMT 和转移。
Mol Med Rep. 2018 May;17(5):7045-7054. doi: 10.3892/mmr.2018.8781. Epub 2018 Mar 20.
5
Effect of platinum‑based chemotherapy on the expression of natural killer group 2 member D ligands, programmed cell death‑1 ligand 1 and HLA class I in non‑small cell lung cancer.铂类化疗对非小细胞肺癌中自然杀伤细胞组 2 成员 D 配体、程序性细胞死亡 1 配体 1 和 HLA Ⅰ类分子表达的影响。
Oncol Rep. 2019 Aug;42(2):839-848. doi: 10.3892/or.2019.7185. Epub 2019 Jun 3.
6
A Crosstalk Between Castration-Resistant Prostate Cancer Cells, M2 Macrophages, and NK Cells: Role of the ATM-PI3K/AKT-PD-L1 Pathway.雄激素非依赖型前列腺癌细胞、M2 型巨噬细胞与自然杀伤细胞之间的串扰:ATM-PI3K/AKT-PD-L1 通路的作用。
Immunol Invest. 2023 Nov;52(8):941-965. doi: 10.1080/08820139.2023.2258930. Epub 2023 Nov 24.
7
In vitro-induced M2 type macrophages induces the resistance of prostate cancer cells to cytotoxic action of NK cells.体外诱导的 M2 型巨噬细胞诱导前列腺癌细胞对 NK 细胞细胞毒性作用的抵抗。
Exp Cell Res. 2018 Mar 1;364(1):113-123. doi: 10.1016/j.yexcr.2018.01.041. Epub 2018 Feb 1.
8
Combined treatment with anti-PSMA CAR NK-92 cell and anti-PD-L1 monoclonal antibody enhances the antitumour efficacy against castration-resistant prostate cancer.抗 PSMA CAR NK-92 细胞与抗 PD-L1 单克隆抗体联合治疗增强了对去势抵抗性前列腺癌的抗肿瘤疗效。
Clin Transl Med. 2022 Jun;12(6):e901. doi: 10.1002/ctm2.901.
9
Curcumol inhibits the expression of programmed cell death-ligand 1 through crosstalk between hypoxia-inducible factor-1α and STAT3 (T705) signaling pathways in hepatic cancer.姜黄素通过缺氧诱导因子-1α和 STAT3(T705)信号通路的串扰抑制肝癌中程序性细胞死亡配体 1 的表达。
J Ethnopharmacol. 2020 Jul 15;257:112835. doi: 10.1016/j.jep.2020.112835. Epub 2020 Apr 9.
10
Hypoxia-induced shedding of MICA and HIF1A-mediated immune escape of pancreatic cancer cells from NK cells: role of circ_0000977/miR-153 axis.缺氧诱导的 MICA 脱落和 HIF1A 介导的胰腺癌细胞对 NK 细胞的免疫逃逸:circ_0000977/miR-153 轴的作用。
RNA Biol. 2019 Nov;16(11):1592-1603. doi: 10.1080/15476286.2019.1649585. Epub 2019 Aug 12.

引用本文的文献

1
Adaptation of Natural Killer Cells to Hypoxia: A Review of the Transcriptional, Translational, and Metabolic Processes.自然杀伤细胞对缺氧的适应性:转录、翻译及代谢过程综述
Immunotargets Ther. 2025 Feb 18;14:99-121. doi: 10.2147/ITT.S492334. eCollection 2025.
2
Transcriptome analysis of anaerobic glycolysis effects on Jurkat T cell proliferation.无氧糖酵解对Jurkat T细胞增殖影响的转录组分析
Cent Eur J Immunol. 2024;49(2):194-202. doi: 10.5114/ceji.2024.142116. Epub 2024 Aug 12.
3
Hypoxic tumor microenvironment: Destroyer of natural killer cell function.

本文引用的文献

1
The JAK/STAT pathway is involved in the upregulation of PD-L1 expression in pancreatic cancer cell lines.JAK/STAT信号通路参与胰腺癌细胞系中PD-L1表达的上调。
Oncol Rep. 2017 Mar;37(3):1545-1554. doi: 10.3892/or.2017.5399. Epub 2017 Jan 23.
2
Posttranscriptional Control of PD-L1 Expression by 17β-Estradiol via PI3K/Akt Signaling Pathway in ERα-Positive Cancer Cell Lines.17β-雌二醇通过PI3K/Akt信号通路对雌激素受体α阳性癌细胞系中PD-L1表达的转录后调控
Int J Gynecol Cancer. 2017 Feb;27(2):196-205. doi: 10.1097/IGC.0000000000000875.
3
Impact of hypoxia inducible factors on estrogen receptor expression in breast cancer cells.
缺氧肿瘤微环境:自然杀伤细胞功能的破坏者。
Chin J Cancer Res. 2024 Apr 30;36(2):138-150. doi: 10.21147/j.issn.1000-9604.2024.02.04.
4
Advances in metabolic reprogramming of NK cells in the tumor microenvironment on the impact of NK therapy.肿瘤微环境中自然杀伤细胞代谢重编程对自然杀伤细胞疗法影响的研究进展
J Transl Med. 2024 Mar 3;22(1):229. doi: 10.1186/s12967-024-05033-w.
5
ANGPTL3 affects the metastatic potential and the susceptibility of ovarian cancer cells to natural killer cell-mediated cytotoxicity.血管生成素样蛋白3(ANGPTL3)影响卵巢癌细胞的转移潜能以及对自然杀伤细胞介导的细胞毒性的敏感性。
Heliyon. 2023 Jul 28;9(8):e18799. doi: 10.1016/j.heliyon.2023.e18799. eCollection 2023 Aug.
6
Functional crosstalk and regulation of natural killer cells in tumor microenvironment: Significance and potential therapeutic strategies.肿瘤微环境中自然杀伤细胞的功能串扰与调控:意义及潜在治疗策略
Genes Dis. 2022 Aug 6;10(3):990-1004. doi: 10.1016/j.gendis.2022.07.009. eCollection 2023 May.
7
PD-L1: expression regulation.程序性死亡受体配体1:表达调控
Blood Sci. 2023 Jan 13;5(2):77-91. doi: 10.1097/BS9.0000000000000149. eCollection 2023 Apr.
8
HIF1α-dependent and independent pathways regulate the expression of PD-L1 in prostate cancer.缺氧诱导因子 1α(HIF1α)依赖性和非依赖性途径调节前列腺癌中 PD-L1 的表达。
Med Oncol. 2023 Apr 17;40(5):151. doi: 10.1007/s12032-023-02017-6.
9
Addressing Natural Killer Cell Dysfunction and Plasticity in Cell-Based Cancer Therapeutics.解决基于细胞的癌症治疗中自然杀伤细胞功能障碍和可塑性问题。
Cancers (Basel). 2023 Mar 13;15(6):1743. doi: 10.3390/cancers15061743.
10
Comprehensive pan-cancer analysis of STAT3 as a prognostic and immunological biomarker.全面泛癌分析 STAT3 作为预后和免疫生物标志物。
Sci Rep. 2023 Mar 28;13(1):5069. doi: 10.1038/s41598-023-31226-2.
缺氧诱导因子对乳腺癌细胞中雌激素受体表达的影响。
Arch Biochem Biophys. 2017 Jan 1;613:23-30. doi: 10.1016/j.abb.2016.11.002. Epub 2016 Nov 5.
4
EAU-ESTRO-SIOG Guidelines on Prostate Cancer. Part II: Treatment of Relapsing, Metastatic, and Castration-Resistant Prostate Cancer.EAU-ESTRO-SIOG 前列腺癌诊治指南。第二部分:复发、转移和去势抵抗性前列腺癌的治疗。
Eur Urol. 2017 Apr;71(4):630-642. doi: 10.1016/j.eururo.2016.08.002. Epub 2016 Aug 31.
5
Predictive value of hypoxia in advanced head and neck cancer after treatment with hyperfractionated radio-chemotherapy and hypoxia modification.超分割放化疗联合低氧修饰治疗晚期头颈癌后低氧的预测价值
Clin Transl Oncol. 2017 Apr;19(4):419-424. doi: 10.1007/s12094-016-1541-x. Epub 2016 Aug 15.
6
Hypoxia-Responsive Mir-301a and Mir-301b Promote Radioresistance of Prostate Cancer Cells via Downregulating NDRG2.缺氧反应性微小RNA-301a和微小RNA-301b通过下调NDRG2促进前列腺癌细胞的放射抗性。
Med Sci Monit. 2016 Jun 21;22:2126-32. doi: 10.12659/msm.896832.
7
PEBP4 silencing inhibits hypoxia-induced epithelial-to-mesenchymal transition in prostate cancer cells.PEBP4基因沉默抑制前列腺癌细胞中缺氧诱导的上皮-间质转化。
Biomed Pharmacother. 2016 Jul;81:1-6. doi: 10.1016/j.biopha.2016.03.030. Epub 2016 Apr 6.
8
Immune escape to PD-L1/PD-1 blockade: seven steps to success (or failure).免疫逃避 PD-L1/PD-1 阻断:成功(或失败)的七个步骤。
Ann Oncol. 2016 Aug;27(8):1492-504. doi: 10.1093/annonc/mdw217. Epub 2016 May 20.
9
Hypoxia inducible factor-1α-dependent epithelial to mesenchymal transition under hypoxic conditions in prostate cancer cells.缺氧诱导因子-1α依赖性上皮间质转化在前列腺癌细胞缺氧条件下。
Oncol Rep. 2016 Jul;36(1):521-7. doi: 10.3892/or.2016.4766. Epub 2016 Apr 25.
10
Anti-PD-L1/PD-1 immune therapies in ovarian cancer: basic mechanism and future clinical application.抗PD-L1/PD-1免疫疗法在卵巢癌中的应用:基本机制与未来临床应用
Int J Clin Oncol. 2016 Jun;21(3):456-61. doi: 10.1007/s10147-016-0968-y. Epub 2016 Mar 11.